T-DXd shows promise in neoadjuvant therapy for HER2(+) breast cancer. Killock D. Nat Rev Clin Oncol 2025 Nov 10. doi: 10.1038/s41571-025-01103.

Read + Share

Amedeo Smart

Independent Medical Education

Killock D. T-DXd shows promise in neoadjuvant therapy for HER2(+) breast cancer. Nat Rev Clin Oncol 2025 Nov 10. doi: 10.1038/s41571-025-01103.
PMID: 41214245